concept designs for vaccine facilities - dcvmn · conceptual design end-points 17 conceptual design...
TRANSCRIPT
![Page 1: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/1.jpg)
Concept designs for vaccine facilities: Conciliation of local and global expectations
DCVMN conference
Klaus Hermansen, Aeby Thomas
27-30 October 2014, New Delhi
![Page 2: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/2.jpg)
Outline
2
• Why Conceptual Design?• What are the objectives of a Conceptual
Design?
• Vaccine facility design.
• Local/ Global expectations.
• Case study: From Conceptual Design to Build
![Page 3: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/3.jpg)
About NNE Pharmaplan
• With 80 years of experience we are passionate about our services to the pharma and biotech industries
• Consulting and engineering for Pharma and Biotech • > 200 with hands-on development or production experience• 30 office locations• 17 countries• 2,929 projects in 2013 (all activities)• Center of Competence (COC) in Bangalore, India for
Global vaccine projects
3
![Page 4: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/4.jpg)
Closer to our customers
NNE Pharmaplan employs close to 1,700 people at more than 30 locations in 16 countries around the world.
4
97% of our revenues
come from the pharma and biotech
industries
COC
![Page 5: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/5.jpg)
Our work split
5
NNE Pharmaplan offer only vendor
independent design solutions
The main part of our employees have a background in pharmaceutical production companies.
![Page 6: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/6.jpg)
NNE Pharmaplan; 75 COI’s , global network –
6
COI Aseptic
Processing
COI Biotech
Production
COI Vaccines
COI Building
Architecture
COI Biocontainment
Next: Session outline
![Page 7: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/7.jpg)
Centre of Competence (COC) for Vaccine Projects (Bangalore)
COC Bangalore
Central Europe
Emerging Markets (BRC)
India
North America
Process Consulting
DelhiCOI Vaccines
(Global)
7
Delhi
Bangalore
![Page 8: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/8.jpg)
What we do – when we do Conceptual Design
8
DEVELOP ESTABLISH IMPROVE
Projectdevelopment
Process & Productdevelopment
Investment projectCD / BD / DD / CON / C&Q
Optimisation, training, revamps,GAP analysis, operational support
![Page 9: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/9.jpg)
Conceptual design of vaccine facilities:3 principal facets
9
Design:1GMP Compliance2Biosafety & Containment Compliance
Technology:1Vaccine mfg. platform &technology2Process/ Equipment
9
Operations:1Manufacturing scheduing 2Operations strategy
![Page 10: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/10.jpg)
Biosafety GMP
�Protect the employees�Prevent escape of materials�Production flow: Clean to dirty!
�Protect the product�Minimize cross contermination�Production flow: Dirty to clean!
To ensure that the product is safe for the end user
To create safe environment for workers/To prevent escape of infectious agents to environment
10
Biosafety versus GMP – an illustration
![Page 11: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/11.jpg)
BSL1 BSL2 BSL3 BSL4
Biosafety Level – ‘Steps’ in Engineering & Operational complexity(related to risk groups of biological agents)
High Containment
11
![Page 12: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/12.jpg)
Why Conceptual design for vaccine facilities?
![Page 13: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/13.jpg)
Why Conceptual Design?
The most important investment, because it ensures:
• Fit for purpose• Technology fit for purpose, manufacturing fit for purpose <broad level of uncertainties>• Understanding of biological agent translated to design measures
• Risk reduction• Limitations and possibilities are identified from the start, facilitating choice awareness• The project is ensured minimum sensitivity to changes during the planning phase• A CD maps possibilities now and going forward, ensuring a firm and time robust solution
• Economy control
• Holistic project approach• A CD provides a cross-disciplinary design which take into account all relevant areas• An overall overview of all project elements is created from the outset
• Sustainability• Environmental considerations are integrated in the project• The sustainability issue might have high impact on image development
• Alignment with business strategy
13
![Page 14: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/14.jpg)
Conceptual design: Basis for Decision v/s Basis for Design
14
Decisionsupport
Pre-design
Conceptual Design Type B
Pre-design
Decisionsupport
Conceptual Design Type A
Decision for manufacturing capability
NO
YES
BasicDesign
GAP
CapEx approved?
START#
![Page 15: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/15.jpg)
• Note: Production program is *key* to Process level feasibility & Configuration level feasibility.
Process level concepts
Suite Configuration level concepts
Site & integration
level concepts
Investment level concepts
Option 1
Option 2
Option 3
4 principal Conceptual foci
15
#
![Page 16: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/16.jpg)
What concept makes the best business case?
16
$ - $$$$/ dose
![Page 17: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/17.jpg)
Conceptual Design end-points
17
Conceptual Design
Commissioning& Qualification
Handover &OperationSupport
BasicDesign
DetailedDesign Construction
Typical pre-design content:•Capacity analyses•Process, utility & building specification•Technology & equipments•Organisation & staffing•Facility area needs•Flow•Layout•Health Safety & Environment•Project execution plan
BasicDesign
Conceptual DesignDecisionsupport
Pre-design
•Cost•Timeline ?
![Page 18: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/18.jpg)
100
80
60
40
20
0
Financial Room for Manoeuvre
CD
CommittedInvestment
Realized ProjectInvestmentCo
nceptu
al Desig
n
Project
Comp
letion
Project Progress (time)
% o
f Tot
al P
roje
ct In
vest
men
t
Investment & Commitment TimelineEarly decisions have most impact on the Investment
Conceptual Design
Comm.& Qual. HandoverBasic
DesignDetailedDesign Construction
Maximum room for manoeuvre for lowest possible cost
The graph illustrates that the major part of investment committed to a project will be determined very early in the project phases, i.e. the very early decisions will have the strongest impact on investment level
18
![Page 19: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/19.jpg)
Conceptual design philosophy
Picasso ”A guitar Player” Vermeer ”A guitar Player”•Possibilities/Inspiration•Open ends•A selection of scopes•Without specific requirements to functions, etc.
•Fixed cost +/- 10%•Without open ends•Well defined scope•Buildable
CD BD
19
![Page 20: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/20.jpg)
Standardised vaccine facilities
![Page 21: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/21.jpg)
Standardised vaccine facility:Flexibility, compliance & construction modularity
21
Main process
Logistics + Support
![Page 22: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/22.jpg)
22
Standardised vaccine facility:Flexibility, compliance & construction modularity
![Page 23: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/23.jpg)
23
Purification chromatography + purification UF/DF rooms = product specific
Standardised vaccine facility:Flexibility, compliance & construction modularity
![Page 24: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/24.jpg)
24
1
2 3 4 5 6
Standardised vaccine facility:Flexibility, compliance & construction modularity
![Page 25: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/25.jpg)
Site/integration level feasibility
25
![Page 26: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/26.jpg)
Case Study
![Page 27: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/27.jpg)
Medigen vaccine facility, Taiwan
• Medigen vaccine facility• Designed for viral vaccines: EV71 and Flu• Option for other Viral products• Designed for Formulation and Filling• State of art facility• Project start: 2012• Expected completion: 2015
27
![Page 28: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/28.jpg)
Design strategy, design drivers
• Vaccine manufacturing units:
• Designed as Multi-product facility • Designed for flexibility and high level segregation• cGMP• BSL2+ for bulk 1• BSL2 for bulk 2• Single use technology where appropriate• Common support functions• Closed system approach in order to lower room classification
28
![Page 29: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/29.jpg)
Containment strategy for vaccine pilot units
• Maximal segregation by:
• Dedicated HVAC units for each unit• 100% fresh air for BSL areas• Advanced pressure regime with lowest pressure in the return
corridor• Uni-directional flow of people for all BSL area• Access control for all airlocks• Dedicated operators for each pilot unit• Decon-area for solid waste in connection to return corridor• Two step de-gowning area before leaving the BSL area• Kill system in basement for decon of liquid waste• Risk based approach•
29
![Page 30: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/30.jpg)
![Page 31: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/31.jpg)
31
![Page 32: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/32.jpg)
Site Plan
32
![Page 33: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/33.jpg)
Section
33
![Page 34: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/34.jpg)
Slides withheld
30 October 201434
• Customer confidential
![Page 35: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/35.jpg)
Slides withheld
30 October 201435
• Customer confidential
![Page 36: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/36.jpg)
Slides withheld
30 October 201436
• Customer confidential
![Page 37: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/37.jpg)
37
Work in progress: Today
![Page 38: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/38.jpg)
Connect with us:
Klaus HermansenSenior Technology PartnerMobile: +45 30 79 31 [email protected]
Aeby ThomasGeneral Manager, ConsultingMobile: +91 120 477 [email protected]
“Rigorous conceptual designs are the foundations strategic vaccine manufacturing capabilities”
![Page 39: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/39.jpg)
Concept designs for vaccine facilities: Conciliation of local and global expectations
DCVMN conference
Klaus Hermansen, Aeby Thomas
27-30 October 2014, New Delhi
![Page 40: Concept designs for vaccine facilities - DCVMN · Conceptual Design end-points 17 Conceptual Design Commissioning & Qualification Handover & Operation Support Basic Design Detailed](https://reader033.vdocuments.net/reader033/viewer/2022042212/5eb533a506610c02e11adfcb/html5/thumbnails/40.jpg)
Consulting Services - Overview
30 October 201440
1. Lean Six Sigma2. PAT3. Lean Operations4. Integrated Automation5. Product and process development
1. Strategy Development 2. Supply Chain Optimisation3. Conceptual Design & Feasibility Studies4. Project Portfolio Management5. Ramp up and Downsizing
1. Project Management2. Competence Development3. Workflow Management4. Change Management5. Project Organisation
People & Organisation
ProcessExcellence
Strategic Consulting
Focus onemployees
Focus onprocesses
Focus ontechnologies
Process & Technology
Focus on business
Customer Values:Optimised
business in all product life cycle phases
GxPCompliance
Focus onregulations
1. Process Design & Optimisation2. Technology Standardisation/Management3. Start up Company Services4. Facility Design & Optimisation5. Human, Safety & Environment (HSE)
1. GMP Reviews2. Process Validation3. Risk Assessment4. Quality Systems Development 5. Supplier Audits